Mereo BioPharma Group plc (NASDAQ MREO), (Mereo or the Company) announced it has filed and mailed a shareholder circular (the Shareholder Circular) and related meeting and proxy materials in connection with its upcoming General Meeting. Mereo is a clinical-stage biopharmaceutical company focused on rare diseases and oncology.
🏢 Related Organizations:
Composition of Mereos Significantly Refreshed Board
the Right Skills and Experience to Guide Mereos Strategy
Maximize Shareholder Value Details Rubrics Rejection of Reasonable Settlement Proposals
Mereo BioPharma Group plc
Company
📅 Key Dates:
October 21
today
November 18, 2022
This filing contains important information for shareholders regarding upcoming corporate events and voting procedures. Shareholders are encouraged to review all materials carefully.
🏛️ Mereo BioPharma (MREO) - Corporate Governance Update
Filing Date: 2022-10-21
Accepted: 2022-10-21 07:06:00
Event Type: Corporate Governance
Meeting Type: Shareholder Meeting
Meeting Date: October 21
Meeting Details:
Mereo BioPharma Group plc (NASDAQ MREO), (Mereo or the Company) announced it has filed and mailed a shareholder circular (the Shareholder Circular) and related meeting and proxy materials in connection with its upcoming General Meeting. Mereo is a clinical-stage biopharmaceutical company focused on rare diseases and oncology.
🏢 Related Organizations:
📅 Key Dates:
This filing contains important information for shareholders regarding upcoming corporate events and voting procedures. Shareholders are encouraged to review all materials carefully.